Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$768M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$625M |
| 3 |
AGN
Allergan plc
AGN
|
+$427M |
| 4 |
McKesson
MCK
|
+$427M |
| 5 |
Johnson Controls International
JCI
|
+$427M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$503M |
| 2 |
RTX Corp
RTX
|
+$457M |
| 3 |
Global Payments
GPN
|
+$441M |
| 4 |
Amazon
AMZN
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.18% |
| 2 | Healthcare | 4.07% |
| 3 | Financials | 2.86% |
| 4 | Industrials | 2.85% |
| 5 | Consumer Discretionary | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8801
Traws Pharma
TRAW
$8.7M
| $55K | ﹤0.01% |
483
+328
| +212% | +$51.5K |
|
|
GPL
8802
DELISTED
Great Panther Mining Limited
GPL
| $55K | ﹤0.01% |
18,049
+5,716
| +46% | +$28.7K |
|
|
GSKY
8803
CALL
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $55K | ﹤0.01% |
+14,500
| New | +$108K |
|
|
ADMS
8804
DELISTED
Adamas Pharmaceuticals
ADMS
| $55K | ﹤0.01% |
19,232
-21,922
| -53% | -$98.2K |
|
|
BDSI
8805
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $55K | ﹤0.01% |
14,400
+1,200
| +9% | +$5.9K |
|
8806
CALL
Cerus
CERS
$601M
| $54K | ﹤0.01% |
+11,600
| New | +$52.5K |
|
|
DRD
8807
CALL
DRDGold
DRD
$2.1B
| $54K | ﹤0.01% |
+10,000
| New | +$60.8K |
|
8808
PUT
Newmark Group
NMRK
$2.76B
| $54K | ﹤0.01% |
12,600
+2,000
| +19% | +$19.6K |
|
8809
PhenixFIN
PFX
$88.3M
| $54K | ﹤0.01% |
+4,674
| New | +$158K |
|
|
SJT
8810
CALL
San Juan Basin Royalty Trust
SJT
$131M
| $54K | ﹤0.01% |
25,600
+12,500
| +95% | +$29.6K |
|
|
NM
8811
DELISTED
Navios Maritime Holdings Inc.
NM
| $54K | ﹤0.01% |
23,244
+4,516
| +24% | +$14.4K |
|
|
AXU
8812
CALL
DELISTED
Alexco Resource Corp
AXU
| $54K | ﹤0.01% |
44,400
+23,500
| +112% | +$39.7K |
|
8813
Aclaris Therapeutics
ACRS
$851M
| $53K | ﹤0.01% |
51,250
+24,479
| +91% | +$33.3K |
|
8814
PUT
Conduent
CNDT
$236M
| $53K | ﹤0.01% |
+21,700
| New | +$86K |
|
8815
PUT
CorMedix
CRMD
$592M
| $53K | ﹤0.01% |
14,900
-900
| -6% | -$5.08K |
|
8816
CALL
Natural Health Trends
NHTC
$15.5M
| $53K | ﹤0.01% |
16,000
-200
| -1% | -$810 |
|
8817
NLI Holdings
NL
$315M
| $53K | ﹤0.01% |
17,920
+3,465
| +24% | +$11.5K |
|
8818
CALL
Navios Maritime Partners
NMM
$2.33B
| $53K | ﹤0.01% |
+10,000
| New | +$109K |
|
|
EVFM
8819
CALL
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $53K | ﹤0.01% |
+667
| New | +$53.4K |
|
|
UNT
8820
DELISTED
UNIT Corporation
UNT
| $53K | ﹤0.01% |
+203,620
| New | +$76.9K |
|
8821
AXT Inc
AXTI
$5.34B
| $52K | ﹤0.01% |
+16,342
| New | +$60.2K |
|
8822
Blink Charging
BLNK
$85.9M
| $52K | ﹤0.01% |
29,864
+6,725
| +29% | +$14.4K |
|
|
BBBY
8823
Bed Bath & Beyond
BBBY
$415M
| $52K | ﹤0.01% |
12,752
-10,370
| -45% | -$56.4K |
|
8824
PUT
Harmony Gold Mining
HMY
$12.1B
| $52K | ﹤0.01% |
23,700
-1,200
| -5% | -$3.94K |
|
8825
Lineage Cell Therapeutics
LCTX
$271M
| $52K | ﹤0.01% |
62,937
-32,043
| -34% | -$31.9K |
|
Similar funds
Ken Griffin's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Griffin held 10,687 positions worth $222B, down 3.5% from $230B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin deployed $36.9B of net new capital in Q1 2020, opening 1,650 new positions and adding to 4,224 existing holdings. Its largest new stake was Invesco QQQ Trust: 2,950,335 shares worth $562M.
By sector, the portfolio is most concentrated in Technology at 4.2% of assets, down from 5.3% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Uber, an estimated $503M trimmed.
- Ken Griffin's largest Q1 2020 buy was Invesco QQQ Trust: 2,950,335 shares worth $562M.
- Ken Griffin added most to Charter Communications in Q1 2020, an estimated $768M increase.
- Ken Griffin's biggest Q1 2020 reduction was Uber, cutting an estimated $503M.
- Ken Griffin fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $280M.
- Ken Griffin's ten largest holdings make up 32% of its $222B portfolio in Q1 2020.
- Ken Griffin opened 1,650 new positions and closed 1,165 in Q1 2020.
- Ken Griffin's portfolio value fell 3.5% quarter-over-quarter to $222B.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.